Dabigatran Etexilate Mesylate is an oral anticoagulant prodrug belonging to the class of direct thrombin inhibitors. Supplied as a white to pale-yellow crystalline powder, it undergoes in vivo conversion to its active form, dabigatran, which selectively inhibits thrombin and prevents fibrin clot formation. The API is widely used in pharmaceutical formulations intended for the prevention of stroke in non-valvular atrial fibrillation and for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). Owing to its sensitivity to moisture, the material is supplied in moisture-protective, pharma-grade packaging to ensure stability under recommended storage conditions.
As a leading distribution partner, Molkem Chemicals ensures reliable supply of products aligned with industry quality standards and regulatory expectations. Each product is delivered as per agreed specifications, supported by standard documentation including COA, SDS, and TDS. If required, our technical team can provide additional stability data and regulatory assistance.